Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients.
Fukushima
M
M
Taniguchi
A
A
Sakai
M
M
Doi
K
K
Nagata
I
I
Nagasaka
S
S
Tokuyama
K
K
Nakai
Y
Y
D044466:Asian People; D001629:Bezafibrate / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D005260:Female; D005905:Glyburide / Q000627:therapeutic use; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood*; D007564:Japan; D008297:Male; D008875:Middle Aged
D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D007328:Insulin; D005905:Glyburide; D001629:Bezafibrate